Clinical Trials Browser

Phase 3 × Enrolling by invitation × Loperamide × Clear all

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma